Resistant Hypertension Clinical Trial
— IberisOfficial title:
Renal Sympathetic Denervation by Iberis System in Patients With Uncontrolled Hypertension - IBERIS - HTN Registry
NCT number | NCT02295683 |
Other study ID # | T124E2 |
Secondary ID | |
Status | Terminated |
Phase | |
First received | |
Last updated | |
Start date | November 2014 |
Est. completion date | September 4, 2017 |
Verified date | October 2019 |
Source | Terumo Europe N.V. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The purpose of this study is to document safety and efficacy of renal sympathetic denervation treatment in subjects with uncontrolled hypertension by using Iberis renal denervation system.
Status | Terminated |
Enrollment | 18 |
Est. completion date | September 4, 2017 |
Est. primary completion date | November 30, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age =18 years or minimum age as required by local regulations. - Patient has been thoroughly informed about this registry and signed Informed Consent Form. - Patient with true resistant hypertension defined as: - Office systolic BP higher than 160 or 150mmHg in case of type 2 diabetes - Ambulatory BP with average BP>130mmHg or mean daytime>135mmHg in more than 70% of the measurements. - Patients should be on stable hypertension therapy for at least 8 weeks before procedure, including spironolactone if they are supposed to be respondent as indicated by the specialized center/excellence unit on hypertension. Exclusion Criteria: - Previous renal artery intervention (balloon angioplasty or stenting). - Evidence of renal artery atherosclerosis (defined as a renal artery stenosis >50%). - Main renal arteries of less than 4mm diameter or less than 20mm in length. - Presence of multiple main renal arteries in either kidney. - Estimated glomerular filtration rate <45ml/min per 1,73m2 - Recent myocardial infarction, unstable angina pectoris or cerebrovascular accident within the past 3-6 months. - False resistant hypertension (pseudo resistance) by using 24h ambulatory BP monitoring (ABPM). - Secondary arterial hypertension. - Pregnancy. - There is another pathological process with well-known life expectancy of less than 5 years. - Patient unable to do correct FU. - Unable to take correct ambulatory BP. - Primary hyperaldosteronism. - Known lack of adherence to medical treatment. |
Country | Name | City | State |
---|---|---|---|
Serbia | Clinical Center of Serbia | Belgrade | |
Spain | Hospital Galdakao | Galdakao |
Lead Sponsor | Collaborator |
---|---|
Terumo Europe N.V. |
Serbia, Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Pressure (BP) Measurements | Office BP; Ambulatory BP; Home BP | Up to 5 year FU |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05545059 -
Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
|
Phase 3 | |
Not yet recruiting |
NCT04388124 -
VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
|
Phase 2 | |
Withdrawn |
NCT01939392 -
Rapid Renal Sympathetic Denervation for Resistant Hypertension II
|
Phase 2/Phase 3 | |
Recruiting |
NCT06228677 -
Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization
|
||
Recruiting |
NCT04213963 -
Prospective Study on Primary Aldosteronism in Resistant Hypertension
|
||
Recruiting |
NCT05563077 -
Aerobic Exercise and Resistant Hypertension
|
N/A | |
Recruiting |
NCT03758196 -
Renal Sympathetic Denervation From the Adventitia on Resistant Hypertension(RSDARH)
|
N/A | |
Active, not recruiting |
NCT03179800 -
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
|
N/A | |
Completed |
NCT04519658 -
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
|
Phase 2 | |
Not yet recruiting |
NCT05552300 -
Superselective Adrenal Arterial Embolization for Resistant Hypertension
|
N/A | |
Not yet recruiting |
NCT05426707 -
Remote Ischemic Conditioning for the Treatment of Resistant Hypertension
|
N/A | |
Completed |
NCT04345198 -
Adrenal Artery Ablation for Primary Aldosteronism With Resistant Hypertension
|
N/A | |
Active, not recruiting |
NCT05562934 -
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.
|
Phase 2 | |
Recruiting |
NCT06034743 -
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
|
Phase 3 | |
Withdrawn |
NCT02926495 -
Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension.
|
N/A | |
Active, not recruiting |
NCT02670681 -
Effects of Aerobic Exercise on Blood Pressure Levels of Resistant Hypertensive Subjects
|
N/A | |
Completed |
NCT02572024 -
The Effect of BATon BP and Sympathetic Function in Resistant Hypertension (The Nordic BAT Study)
|
N/A | |
Completed |
NCT02001350 -
Carotid Ultrasound Study
|
N/A | |
Recruiting |
NCT04331691 -
Comparison of Spironolactone and Amiloride on Home Blood Pressure in Resistant Hypertension
|
Phase 4 | |
Recruiting |
NCT04637152 -
Sacubitril/Valsartan in Resistant Hypertension
|
Phase 2 |